Dimension logo

Dimension

North America, New York, United States, New York

Description

Dimension is a first-of-its-kind firm partnering with founders at the interface of technology and life sciences

Investor Profile

Dimension has backed more than 13 startups, with 6 new investments in the last 12 months alone. The firm has led 7 rounds, about 54% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Germany.
  • Strong thematic focus on Biotechnology, Therapeutics, Pharmaceutical.
  • Led 3 rounds in the past year.

Stage Focus

  • Seed (38%)
  • Series B (31%)
  • Series A (15%)
  • Series Unknown (8%)
  • Pre Seed (8%)

Country Focus

  • United States (62%)
  • United Kingdom (15%)
  • Germany (15%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Life Science
  • Data Integration
  • Software Engineering
  • Clinical Trials
  • Health Care
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dimension frequently co-invest with?

Wireframe Ventures
North America, California, United States, Mill Valley
Co-Investments: 2
Possible Ventures
Europe, Bayern, Germany, Munich
Co-Investments: 2
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 2
Caffeinated Capital
North America, California, United States, San Francisco
Co-Investments: 2
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 3
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 2
FPV Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Pioneer Fund
North America, California, United States, San Francisco
Co-Investments: 2
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does Dimension often collaborate with?

AK
North America, California, United States, San Francisco
Shared Deals: 1
NB
North America, New York, United States, New York
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 1
HK
North America, New York, United States, New York
Shared Deals: 1
FE
North America, California, United States, San Francisco
Shared Deals: 2
GT
North America, California, United States, San Francisco
Shared Deals: 2
EG
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Dimension?

Verisian

London, England, United Kingdom

Accelerate drug time to market through real study traceability and unparalleled trial integrity

PharmaceuticalSoftware
SeedMay 29, 2025
Amount Raised: $4,300,000
Lamin

Munich, Bayern, Germany

Open data platform for biology.

Artificial Intelligence (AI)BiotechnologyData IntegrationData ManagementData StorageSoftware Engineering
SeedMay 10, 2025
NewLimit

South San Francisco, California, United States

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

BiotechnologyClinical TrialsHealth Care
Series BMay 6, 2025
Amount Raised: $130,000,000
Stately Bio

Chicago, Illinois, United States

Stately Bio is the trade-off between measuring cells and keeping them alive.

Biotechnology
SeedMay 1, 2025
Amount Raised: $12,000,000
Achira

New York, New York, United States

Achira, a startup combining AI and physics-based methods for drug discovery.

BiotechnologyMedicalSimulation
SeedFeb 24, 2025
Amount Raised: $33,000,000
Aspect Biosystems

Vancouver, British Columbia, Canada

Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.

BiotechnologyLife Science
Series BJan 8, 2025
Amount Raised: $115,000,000
Kimia Therapeutics

Berkeley, California, United States

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

BiotechnologyTherapeutics
Series ADec 19, 2023
Amount Raised: $55,000,000
Automata

London, England, United Kingdom

Automata is a biotechnology company that provides workflow automation for the life sciences industry.

Artificial Intelligence (AI)BiotechnologyLife ScienceRobotics
Series UnknownOct 3, 2023
Amount Raised: $40,000,000
NewLimit

South San Francisco, California, United States

NewLimit is creating epigenetic reprogramming medications to cure diseases with significant unmet medical needs.

BiotechnologyClinical TrialsHealth Care
Series AMay 16, 2023
Amount Raised: $40,000,000
Enveda Biosciences

Boulder, Colorado, United States

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 20, 2023
Amount Raised: $51,000,000